FDA update on ADRs associated with arginine

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1259, 2009-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical anaesthetics: FDA warns of potential life-threatening ADRs

By  

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Update on the Office of Drug Safety at the US FDA

By  

Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Rituxan associated with PML, warns US FDA

By  

Reactions Weekly, Vol. 1, Iss. 1133, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Rituxan associated with PML, warns US FDA

By  

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation

By  

Current Drug Targets, Vol. 16, Iss. 7, 2015-01 ,pp. : 700-710

Bentham Science Publishers

Access to resources Recommend Favorite